- Home
- LSBK vs NSPR Comparison
LSBK vs NSPR Comparison
Compare LSBK & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- NSPR
- Stock Information
- Founded
- LSBK 1891
- NSPR 2005
- Country
- LSBK United States
- NSPR Israel
- Employees
- LSBK N/A
- NSPR N/A
- Industry
- LSBK Savings Institutions
- NSPR Medical/Dental Instruments
- Sector
- LSBK Finance
- NSPR Health Care
- Exchange
- LSBK Nasdaq
- NSPR Nasdaq
- Market Cap
- LSBK 77.2M
- NSPR 63.0M
- IPO Year
- LSBK 2006
- NSPR N/A
- Fundamental
- Price
- LSBK $13.70
- NSPR $2.91
- Analyst Decision
- LSBK
- NSPR Strong Buy
- Analyst Count
- LSBK 0
- NSPR 2
- Target Price
- LSBK N/A
- NSPR $4.75
- AVG Volume (30 Days)
- LSBK 955.0
- NSPR 78.6K
- Earning Date
- LSBK 01-29-2025
- NSPR 11-12-2024
- Dividend Yield
- LSBK 5.20%
- NSPR N/A
- EPS Growth
- LSBK N/A
- NSPR N/A
- EPS
- LSBK 0.74
- NSPR N/A
- Revenue
- LSBK $25,338,000.00
- NSPR $6,821,000.00
- Revenue This Year
- LSBK N/A
- NSPR $13.31
- Revenue Next Year
- LSBK N/A
- NSPR $52.91
- P/E Ratio
- LSBK $18.65
- NSPR N/A
- Revenue Growth
- LSBK N/A
- NSPR 24.70
- 52 Week Low
- LSBK $10.30
- NSPR $1.81
- 52 Week High
- LSBK $14.21
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- LSBK 62.66
- NSPR 52.69
- Support Level
- LSBK $13.44
- NSPR $2.78
- Resistance Level
- LSBK $13.67
- NSPR $3.15
- Average True Range (ATR)
- LSBK 0.02
- NSPR 0.22
- MACD
- LSBK 0.05
- NSPR -0.03
- Stochastic Oscillator
- LSBK 100.00
- NSPR 47.58
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.